The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.
about
Mechanism and significance of cell type-dependent neutralization of flavivirusesBroadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral SerotypeDeconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and ImmunityDengue: knowledge gaps, unmet needs, and research prioritiesA single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesisAntibody responses to Zika virus infections in flavivirus-endemic environmentsParticle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.Rapid development of a DNA vaccine for Zika virusVariation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination.Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive AntibodiesContext-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus AssemblyEvolutionarily Successful Asian 1 Dengue Virus 2 Lineages Contain One Substitution in Envelope That Increases Sensitivity to Polyclonal Antibody Neutralization.Dengue viruses cluster antigenically but not as discrete serotypesA game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development.Broad and strong: the ultimate antibody to dengue virus.Dengue virus envelope protein domain I/II hinge: a key target for dengue virus vaccine design?Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4.Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies.
P2860
Q23032973-2C2DE3D0-B346-47A2-9E3A-ADE339AFAB30Q26252060-C4CCABFA-EF70-4440-A610-B10332735BA7Q27654848-7FF021FF-2281-400A-B619-270C336452B1Q28729764-140BED8B-4FE9-464F-83E7-96CAE4F2AEC6Q28804076-948CA617-A4CF-4ADA-AAF3-34710732CAE8Q28827957-900C6FA7-1AEF-4ED2-9571-6D59A38F4D0EQ34059136-15D1A858-BD61-4AAC-85CE-B80BE2F1549CQ34542032-200E2F63-9E5D-43A2-B04B-F70268441685Q34594111-D62477B1-423B-45FD-8377-FC4FA5394A77Q35294150-E7EBCBB8-6167-40E2-B745-CFCD4D788E62Q35758626-28884061-A2F5-464B-8B0B-A10B38BA98B8Q35914284-BEAC337D-7F9A-4999-8C18-A5A7CA59DF89Q36597801-2504542C-CFD1-4F9D-BFD2-A54B032987B9Q36926525-A62747A1-3E26-4FCE-B752-5B8A5C6789F5Q37012203-112AD801-B1AD-430D-978A-AB2D670D4584Q39535403-769E60DE-D430-4F3D-A122-CD1E2384DF3EQ40173610-E2809012-8582-48D3-B377-8D811F3912BDQ43038900-3A3001E3-AB83-4043-BC4E-60F62B62044FQ45323668-5AA2F454-371D-44EF-B868-A226D96830D6Q47562022-E41C6A55-64D4-4402-AED9-9B3A9CCF70EA
P2860
The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The type-specific neutralizing ...... acids of the envelope protein.
@ast
The type-specific neutralizing ...... acids of the envelope protein.
@en
type
label
The type-specific neutralizing ...... acids of the envelope protein.
@ast
The type-specific neutralizing ...... acids of the envelope protein.
@en
prefLabel
The type-specific neutralizing ...... acids of the envelope protein.
@ast
The type-specific neutralizing ...... acids of the envelope protein.
@en
P2860
P50
P1433
P1476
The type-specific neutralizing ...... acids of the envelope protein.
@en
P2093
Laura A VanBlargan
Swati Mukherjee
P2860
P304
P356
10.1371/JOURNAL.PPAT.1003761
P577
2013-12-05T00:00:00Z